Gap junction intercellular communication in carcinogenesis of endometrial cancer;Komunikacja mie{ogonek}dzykomórkowa z udziałem poła{ogonek}czeń typu gap w karcinogenezie błony śluzowej trzonu macicy

Ginekologia Polska

Volumn 82, Issue 7, 2011, Pages 520-524

  Marek, Baltaziak ^a   Luiza, Kańczuga Koda ^b   Ryszard, Rutkowski ^c   Marcin, Musiatowicz ^d   Mariusz, Koda ^a   Ryszard, Leśniewicz ^e   Urszula, Sulkowska ^f   Monika, Baltaziak ^f   Tomasz, Leśniewicz ^a   Stanisław, Sulkowski ^a  

^a Zak ad Biochemii Lekarskiej   (Poland)

^b Zak ad Patomorfologii Regionalnego O rodka Onkologicznego   (Poland)

^c Samodzielna Pracownia Diagnostyki Oddechowej i Bronchoskopii AM   (Poland)

^d Klinika Otolaryngologii AM   (Poland)

^e Klinika Rozrodczo ci i Endokrynologii Ginekologicznej   (Poland)

^f NONE   (Poland)

Author keywords

Adhesion proteins; Connexins; Endometrial cancer; Intercellular communication

Indexed keywords

GAP JUNCTION PROTEIN;

CELL COMMUNICATION; CELL JUNCTION; CELL TRANSFORMATION; ENDOMETRIUM TUMOR; FEMALE; HUMAN; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

CELL COMMUNICATION; CELL TRANSFORMATION, NEOPLASTIC; CONNEXINS; ENDOMETRIAL NEOPLASMS; FEMALE; GAP JUNCTIONS; HUMANS; SIGNAL TRANSDUCTION;

EID: 80052090211     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Doll A, Abal M, Rigau M, [et al.]. Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol. 2008, 108, 221-229.
2. Al Kushi A, Lim P, Aquino-Parsons C, Gilks C. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium. Mod Pathol. 2002, 15, 365-371.
3. Bidziński M, Dańska-Bidzińska A, Derlatka P, [i wsp.]. Recurrence risk analysis in patients treated for I clinical stage of endometrial cancer. Ginekol Pol. 2007, 78, 471-475.
4. Kanczuga-Koda L, Koda M, Sulkowski S, [i wsp.]. Gradual loss of functional gap junction within progression of colorectal cancer - a shift from membranous CX32 and CX43 expression to cytoplasmic pattern during colorectal carcinogenesis. In Vivo. 2010, 24, 101-107.
5. Leśniewicz T, Kanczuga-Koda L, Baltaziak M, [i wsp.]. Comparative evaluation of estrogen and progesterone receptor expression with connexins 26 and 43 in endometrial cancer. Int J Gynecol Cancer. 2009, 19, 1253-1257.
6. Meşe G, Richard G, White T. Gap junctions: basic structure and function. J Invest Dermatol. 2007, 127, 2516-2524.
7. Söhl G, Willecke K. An update on connexin genes and their nomenclature in mouse and man. Cell Commun Adhes. 2003, 10, 173-180.
8. Andrade-Rozental A, Rozental R, Hopperstad M, [et al.]. Gap junctions: the "kiss of death" and the "kiss of life" . Brain Res Brain Res Rev. 2000, 32, 308-315.
9. Krutovskikh V, Piccoli C, Yamasaki H. Gap junction intercellular communication propagates cell death in cancerous cells. Oncogene. 2002, 21, 1989-1999.
10. Vinken M, Vanhaecke T, Papeleu P, [et al.]. Connexins and their channels in cell growth and cell death. Cell Signal. 2006, 18, 592-600.
11. Azzam E, de Toledo S, Little J. Stress signaling from irradiated to non-irradiated cells. Curr Cancer Drug Targets. 2004, 4, 53-64.
12. Zhou H, Randers-Pehrson G, Suzuki M, [et al.]. Genotoxic damage in non-irradiated cells: contribution from the bystander effect. Radiat Prot Dosimetry. 2002, 99, 227-232.
13. Mesnil M, Crespin S, Avanzo J, Zaidan-Dagli M. Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta. 2005, 1719, 125-145.
14. Trosko J, Chang C, Upham B, Tai M. Ignored hallmarks of carcinogenesis: stem cells and cellcell communication. Ann N Y Acad Sci. 2004, 1028, 192-201.
15. Frank D, Szymkowiak B, Josifovska-Chopra O, [et al.]. Single-cell microinjection of cytochrome c can result in gap junction-mediated apoptotic cell death of bystander cells in head and neck cancer. Head Neck. 2005, 27, 794-800.
16. Tanaka M, Grossman HB. Connexin 26 induces growth suppression, apoptosis and increased efficacy of doxorubicin in prostate cancer cells. Oncol Rep. 2004, 11, 537-541.
17. Wang M, Berthoud VM, Beyer E. Connexin43 increases the sensitivity of prostate cancer cells to TNFalfa-induced apoptosis. J Cell Sci. 2007, 120, 320-329.
18. Qin H, Shao Q, Curtis H, [et al.]. Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J Biol Chem. 2002, 277, 29132-29138.
19. Mesnil M, Krutovskikh V, Piccoli C, [et al.]. Negative growth control of HeLa cells by connexin genes: connexin species specificity. Cancer Res. 1995, 55, 629-639.
20. Kanczuga-Koda L, Sulkowski S, Koda M, [et al.]. Connexin 26 correlates with Bcl-xL and Bax proteins expression in colorectal cancer. World J Gastroenterol. 2005, 11, 1544-1548.
21. Evans W, De Vuyst E, Leybaert L. The gap junction cellular internet: connexin hemichannels enter the signalling limelight. Biochem J. 2006, 397, 1-14.
22. Grümmer R, Chwalisz K, Mulholland J, [et al.]. Regulation of connexin26 and connexin43 expression in rat endometrium by ovarian steroid hormones. Biol Reprod. 1994, 51, 1109-1116.
23. Jahn E, Classen-Linke I, Kusche M, [et al.]. Expression of gap junction connexins in the human endometrium throughout the menstrual cycle. Hum Reprod. 1995, 10, 2666-2670.
24. Saito T, Oyamada M, Yamasaki H, [et al.]. Co-ordinated expression of connexins 26 and 32 in human endometrial glandular epithelium during the reproductive cycle and the influence of hormone replacement therapy. Int J Cancer. 1997, 73, 479-485.
25. Winterhager E, Grümmer R, Mavrogianis P. Connexin expression pattern in the endometrium of baboons is influenced by hormonal changes and the presence of endometriotic lesions. Mol Hum Reprod. 2009, 15, 645-652.
26. Granot I, Dekel N, Bechor E. Temporal analysis of connexin43 protein and gene expression throughout the menstrual cycle in human endometrium. Fertil Steril. 2000, 73, 381-386
27. Grümmer R, Traub O, Winterhager E. Gap junction connexin genes Cx26 and Cx43 are differentially regulated by ovarian steroid hormones in rat endometrium. Endocrinology. 1999, 140, 2509-2516.
28. Risek B, Klier F, Phillips A. Gap junction regulation in the uterus and ovaries of immature rats by estrogen and progesterone. J Cell Sci. 1995, 108, 1017-1032.
29. Mesnil M, Krutovskikh V, Piccoli C, [et al.]. Negative growth control of HeLa cells by connexin genes: connexin species specificity. Cancer Res. 1995, 55, 629-639.
30. Trosko J, Chang C. Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer. Mutat Res. 2001, 480-481, 219-229
31. Zhang W, Li H-G, Fan M-J, [et al.]. Expressions of connexin 32 and 26 and their correlation to prognosis of non-small cell lung cancer. Ai Zheng. 2009, 8, 173-176.
32. Li Z, Zhou Z, Welch D, Donahue H. Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clin Exp Metastasis. 2008, 25,893-901.
33. Kanczuga-Koda L, Sulkowski S, Koda M, [et al.]. Expression of connexins 26, 32 and 43 in the human colon - an immunohistochemical study. Folia Histochem Cytobiol. 2004, 42, 203-207.
34. Saito T, Nishimura M, Kudo R, Yamasahi H. Suppressed gap junctional intercellular communication in carcinogenesis of endometrium. Int J Cancer. 2001, 93, 317-323.
35. Lesniewicz T, Kanczuga-Koda L, Baltaziak M, [et al.]. Comparative evaluation of estrogen and progesterone receptor expression with connexins 26 and 43 in endometrial cancer. Int J Gynecol Cancer. 2009, 19, 1253-1257.
36. Traub O, Eckert R, Lichtenberg-Frate H, [et al.]. Immunochemical and electrophysiological characterization of murine connexin40 and -43 in mouse tissues and transfected human cells. Eur J Cell Biol. 1994, 64, 101- 112.
37. Koffler L, Roshong S, Kyu PI, Kyu-Park J. Growth inhibition in G(1) and altered expression of cyclin D1 and p27(kip-1) after forced connexin expression in lung and liver carcinoma cells. J. Cell Biochem. 2000, 79, 347-354.
38. Kanczuga-Koda L, Sulkowska M, Koda M, [et al.]. Increased expression of gap junction protein - connexin 32 in lymph node metastases of human ductal breast cancer. Folia Histochem Cytobiol. 2007, 45(Suppl 1), 175- 180.
39. Mesnil M. Connexins and cancer. Biol Cell. 2002, 94, 493-500.
40. King T, Bertram J. Connexins as targets for cancer chemoprevention and chemotherapy. Biochim Biophys Acta. 2005, 1719, 146-160.
41. Wincewicz A, Baltaziak M, Kanczuga-Koda L, [et al.]. Aberrant distributions and relationships among E-cadherin, beta-catenin, and connexin 26 and 43 in endometrioid adenocarcinomas. Int J Gynecol Pathol. 2010, 29, 358-365.
42. Defamie N, Mograbi B, Roger C, [et al.]. Disruption of gap junctional intercellular communication by lindane is associated with aberrant localization of connexin43 and zonula occludens-1 in 42GPA9 Sertoli cells. Carcinogenesis. 2001, 22, 1537-1542.
43. Hulka B. Links between hormone replacement therapy and neoplasia. Fertil Steril. 1994, 62, 168S-175S.
44. Saito T, Schlegel R, Andresson T, [et al.]. Induction of cell transformation by mutated 16K vacuolar H+-atpase (ductin) is accompanied by down-regulation of gap junctional intercellular communication and translocation of connexin 43 in NIH3T3 cells. Oncogene. 1998, 7, 1673-1680.
45. Tsai H, Werber J, Davia M, [et al.]. Reduced connexin 43 expression in high grade, human prostatic adenocarcinoma cells. Biochem Biophys Res Commun. 1996, 227, 64-69.
46. Brehm R, Rüttinger C, Fischer P, [et al.]. Transition from preinvasive carcinoma in situ to seminoma is accompanied by a reduction of connexin 43 expression in Sertoli cells and germ cells. Neoplasia. 2006, 8, 499-509.
47. Saito T, Tanaka R, Wataba K, [et al.]. Overexpression of estrogen receptor-alpha gene suppresses gap junctional intercellular communication in endometrial carcinoma cells. Oncogene. 2004, 23, 1109-1116.
48. Nishimura M, Saito T, Yamasaki H, Kudo R. Suppression of gap junctional intercellular communication via 5' CpG island methylation in promoter region of E-cadherin gene in endometrial cancer cells. Carcinogenesis. 2003, 24, 1615-1623.
49. Jongen W, Fitzgerald D, Asamoto M, [et al.]. Regulation of connexin 43-mediated gap junctional intercellular communication by Ca2+ in mouse epidermal cells is controlled by E-cadherin. J Cell Biol. 1991, 114, 545-555.
50. Fujimoto K, Nagafuchi A, Tsukita S, [et al.]. Dynamics of connexins, E-cadherin and alphacatenin on cell membranes during gap junction formation. J Cell Sci. 1997, 110, 311-322.
51. Hsu M, Andl T, Li G, [et al.]. Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J Cell Sci. 2000, 113, 1535-1542.
52. Meyer R, Laird D, Revel J, Johnson R. Inhibition of gap junction and adherens junction assembly by connexin and A-CAM antibodies. J Cell Biol. 1992, 119, 179-189.
53. Hernandez-Blazquez F, Joazeiro P, Omori Y, Yamasaki H. Control of intracellular movement of connexins by E-cadherin in murine skin papilloma cells. Exp Cell Res. 2001, 270, 235-247.
54. Wojciechowski M, Krawczyk T, Śmigielski J, Malinowski A. The role of adhesive molecules in endometrial cancer: part I. Przegla{ogonek}d Menopauzalny. 2010, 5, 291-292.
55. Miyamoto S, Baba H, Kuroda S, [et al.]. Changes in E-cadherin associated with cytoplasmic molecules in well and poorly differentiated endometrial cancer. Br J Cancer. 2000, 83, 1168-1175.